Please login to the form below

Not currently logged in
Email:
Password:

Sanofi nominates Bonnie Bassler to board

She has over 20 years of experience
Bonnie Bassler

Sanofi has nominated Bonnie Bassler as an independent member of its board of directors.

Bassler serves as a member of the US National Science Board, as appointed by president Barack Obama, which oversees the National Science Foundation.

Her appointment comes shortly after Sanofi's board sacked CEO Christoper Viehbacher.

Commenting on her nomination, Bassler said: “It is a great honour for me to join Sanofi's board of directors. Sanofi is one of the leading international pharmaceutical companies in the world and I look forward to working closely with members on the board and the company to support Sanofi's mission to develop and introduce innovative therapies.”

Bassler has more than 20 years of experience in the sector and is a Howard Hughes Medical Institute investigator, professor in molecular biology and chair of the department of molecular biology at Princeton University, US.

She also serves on oversight, grant, fellowship and award panels for organisations including the National Academies of Sciences and US National Institutes of Health.

Serge Weinberg, chairman of the board and interim CEO at Sanofi, said: “Professor Bassler's scientific expertise in molecular biology and her great leadership skills makes her an outstanding addition to our board.

“We look forward to her contribution to Sanofi's strategy as we continue to innovate and introduce new medicines and vaccines that can help improve health outcomes.”

27th November 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics